Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
cancer immunotherapy
6
×
europe blog main
6
×
europe top stories
fda
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amag pharmaceuticals
clinical trials
gilead sciences
investing
philadelphia blog main
philadelphia top stories
startups
alzheimer's disease
What
bio
roundup
cancer
days
amid
bombast
caught
coronavirus
debate
develop
discussion
efforts
ipo
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
abbvie’s
acquisitions
ahead
alliance
announced
arrival
biofourmis
biotech
bristol
bucks
buy
calls
celebrate
ceo
chance
changing
collabs
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More